We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+11.6%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$169M
AUM Growth
-$76.8M
Cap. Flow
-$93.2M
Cap. Flow %
-55.03%
Top 10 Hldgs %
46.89%
Holding
105
New
8
Increased
16
Reduced
63
Closed
15

Top Buys

Rank Stock Value
1
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$1.53M
2
LEGN icon
Legend Biotech
LEGN
+$1.34M
3
ZLAB icon
Zai Lab
ZLAB
+$1.34M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$1.18M
5
BPMC
Blueprint Medicines
BPMC
+$1.1M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$11.2M
2
UNH icon
UnitedHealth
UNH
+$7.66M
3
MRK icon
Merck
MRK
+$7.43M
4
ABBV icon
AbbVie
ABBV
+$5.44M
5
ABT icon
Abbott
ABT
+$5.14M

Sector Composition

Rank Sector Weight
1 Healthcare 99.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZLAB icon
26
Zai Lab
ZLAB
$2.06B
$1.76M 1.04%
72,870
+70,870
+3,544% +$1.34M
EW icon
27
Edwards Lifesciences
EW
$49.6B
$1.71M 1.01%
25,850
+10,200
+65% +$741K
PCVX icon
28
Vaxcyte
PCVX
$7.81B
$1.66M 0.98%
14,540
-19,190
-57% -$1.73M
CVS icon
29
CVS Health
CVS
$133B
$1.6M 0.95%
25,500
-13,500
-35% -$788K
BNTX icon
30
BioNTech
BNTX
$22.9B
$1.56M 0.92%
13,155
-14,110
-52% -$1.3M
SRPT icon
31
Sarepta Therapeutics
SRPT
$1.57B
$1.54M 0.91%
12,316
-1,180
-9% -$163K
SGOV icon
32
iShares 0-3 Month Treasury Bond ETF
SGOV
$99.4B
$1.53M 0.9%
+15,200
New +$1.53M
CYTK icon
33
Cytokinetics
CYTK
$10.5B
$1.51M 0.89%
28,593
-8,290
-22% -$462K
FOLD
34
DELISTED
Amicus Therapeutics
FOLD
$1.51M 0.89%
141,335
-75,509
-35% -$822K
ISRG icon
35
Intuitive Surgical
ISRG
$127B
$1.5M 0.89%
3,050
-2,350
-44% -$1.09M
ZBH icon
36
Zimmer Biomet
ZBH
$18.2B
$1.46M 0.86%
13,500
-13,150
-49% -$1.44M
NBIX icon
37
Neurocrine Biosciences
NBIX
$16.8B
$1.44M 0.85%
12,515
+8,580
+218% +$1.18M
SPRY icon
38
ARS Pharmaceuticals
SPRY
$509M
$1.43M 0.84%
98,640
-138,297
-58% -$1.64M
BPMC
39
DELISTED
Blueprint Medicines
BPMC
$1.38M 0.82%
14,920
+11,070
+288% +$1.1M
MLTX icon
40
MoonLake Immunotherapeutics
MLTX
$1.57B
$1.37M 0.81%
27,258
+5,830
+27% +$273K
DHR icon
41
Danaher
DHR
$137B
$1.33M 0.78%
4,775
-12,950
-73% -$3.43M
LEGN icon
42
Legend Biotech
LEGN
$3.59B
$1.33M 0.78%
27,200
+25,200
+1,260% +$1.34M
ICLR icon
43
Icon
ICLR
$12.6B
$1.32M 0.78%
4,608
-3,420
-43% -$1.08M
OPCH icon
44
Option Care Health
OPCH
$3.45B
$1.25M 0.74%
40,000
-25,000
-38% -$767K
BIIB icon
45
Biogen
BIIB
$30B
$1.17M 0.69%
6,027
-110
-2% -$23K
RCUS icon
46
Arcus Biosciences
RCUS
$3.55B
$1.15M 0.68%
75,522
-2,863
-4% -$45.1K
ARVN icon
47
Arvinas
ARVN
$518M
$1.13M 0.67%
45,830
+11,000
+32% +$287K
EVH icon
48
Evolent Health
EVH
$348M
$1.1M 0.65%
39,000
-45,000
-54% -$1.16M
GPCR icon
49
Structure Therapeutics
GPCR
$3.41B
$1.07M 0.63%
24,395
+11,030
+83% +$427K
NARI
50
DELISTED
Inari Medical, Inc. Common Stock
NARI
$1.03M 0.61%
25,000
-15,500
-38% -$744K
1
2
3 4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Sectoral Asset Management held 105 positions worth $169M, down 31% from $246M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sectoral Asset Management withdrew a net $93.2M in Q3 2024, closing 15 positions and reducing 63 holdings. Its most notable exit was Elevance Health, an estimated $2.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in iShares 0-3 Month Treasury Bond ETF worth $1.53M.

  • Sectoral Asset Management's largest Q3 2024 buy was iShares 0-3 Month Treasury Bond ETF: 15,200 shares worth $1.53M.
  • Sectoral Asset Management added most to Legend Biotech in Q3 2024, an estimated $1.34M increase.
  • Sectoral Asset Management's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $11.2M.
  • Sectoral Asset Management fully exited Elevance Health in Q3 2024, selling an estimated $2.44M.
  • Sectoral Asset Management's ten largest holdings make up 47% of its $169M portfolio in Q3 2024.
  • Sectoral Asset Management opened 8 new positions and closed 15 in Q3 2024.
  • Sectoral Asset Management's portfolio value fell 31% quarter-over-quarter to $169M.

Based on Sectoral Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.